Drugs for Body Mass Index Quantitative Trait Locus 11 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 934)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Vildagliptin |
Approved, Investigational |
Phase 4 |
|
274901-16-5 |
6918537 |
Synonyms:
(2S)-(((3-Hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile
EQUA
Galvus
Galvus®|LAF-237|NVP-LAF237
Jalra
LAF 237
LAF237
LAF-237
|
NVP LAF237
NVP-LAF 237
NVP-LAF237
NVP-LAF-237
Vildagliptin
Vildagliptina
Xiliarx
|
|
2 |
|
Lactitol |
Approved, Investigational |
Phase 4 |
|
585-86-4 |
157355 |
Synonyms:
4-O-beta-D-Galactopyranosyl-D-glucitol
4-O-β-D-Galactopyranosyl-D-glucitol
D-Lactitol
Emportal
Importal
Lactitol
|
Lactitolum
Neda lactiv importal
Oponaf
Pizensy
WURCS=2.0/2,2,1/[H2122H][a2112h-1b_1-5]/1-2/a4-b1
|
|
3 |
|
Dexlansoprazole |
Approved, Investigational |
Phase 4 |
|
138530-94-6 |
9578005 |
Synonyms:
(+)-LANSOPRAZOL
(R)-LANSOPRAZOLE
2-((R)-((3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)-2-PYRIDINYL)METHYL)SULFINYL)-1H-BENZIMIDAZOLE
DEXILANT
DEXILANT SOLUTAB
DEXLANSOPRAZOLE
KAPIDEX
|
LANSOPRAZOLE R-FORM
R-lansoprazole
T 168390
T-168390
TAK 390
TAK-390
|
|
4 |
|
Lansoprazole |
Approved, Investigational |
Phase 4 |
|
103577-45-3 |
3883 |
Synonyms:
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole
A-65006
Abbot brand OF lansoprazole
AG 1749
AG-1749
Agopton
Almirall brand OF lansoprazole
Amarin
Aprazol
Bamalite
Biuret
Biuret Gr
Biuret Reagent
Biuret Reagent Solution
Blason
Compraz
Dakar
Hoechst brand OF lansoprazole
Hormona brand OF lansoprazole
Ilsatec
Ketian
Lancid
Lanfast
Lanproton
Lansol
Lansopep
Lansophed
Lansoprazol
Lansoprazol [INN-Spanish]
LANSOPRAZOLE
Lansoprazole [Usan:Ban:Inn]
Lansoprazole abbot brand
Lansoprazole almirall brand
Lansoprazole hoechst brand
Lansoprazole hormona brand
Lansoprazole lederle brand
Lansoprazole promeco brand
Lansoprazole salvar brand
Lansoprazole sodium
Lansoprazole takeda brand
Lansoprazole tap brand
Lansoprazole tecnobio brand
Lansoprazole vinas brand
Lansoprazole wyeth brand
Lansoprazoles
Lansoprazolum
|
Lansoprazolum [INN-Latin]
Lansox
Lanston
Lanz
Lanzo
Lanzol
Lanzol-30
Lanzopral
Lanzor
Lanzul
Lapraz
Lasoprol
Lederle brand OF lansoprazole
Limpidex
Linamarin
Mesactol
Monolitum
Ogast
Ogastro
Opiren
Prevacid
PREVACID (TN)
PREVACID 24HR
PREVACID DELAYED RELEASE
PREVACID IV
PREVACID SOLUTAB
Prevpac
Prezal
Pro ulco
Promeco
promeco Brand OF lansoprazole
Promp
Prosogan
Salvar brand OF lansoprazole
Sodium, lansoprazole
Suprecid
Takeda brand OF lansoprazole
Takepron
TAP brand OF lansoprazole
tecnobio Brand OF lansoprazole
Ulpax
Vinas brand OF lansoprazole
Wyeth brand OF lansoprazole
Zoprol
Zoton
|
|
5 |
|
Indapamide |
Approved |
Phase 4 |
|
26807-65-8 |
3702 |
Synonyms:
CARDIDE SR
ETHIBIDE XL
HYPEN SR
Indapamid
Indapamida
Indapamide
Indapamidum
INDAXA 2.5
INDIPAM XL
KYD-041
Lozol
MAPEMID XL
|
Metindamide
NATRILIX
NATRILIX SR
Natrix
NINDAXA 2.5
OPUMIDE 2.5
RAWEL XL
S-1520
SE-1520
TENSAID XL
VARBIM XL
|
|
6 |
|
Insulin lispro |
Approved |
Phase 4 |
|
133107-64-9 |
16132438 |
Synonyms:
ADMELOG
ADMELOG SOLOSTAR
HUMALOG
HUMALOG KWIKPEN
HUMALOG PEN
INS HUMALOG
INSULIN LISPRO
Insulin lispro (genetical recombination)
|
Insulin lispro (rDNA origin)
Insulin lispro protamine
Insulin lispro protamine recombinant
INSULIN LISPRO RECOMBINANT
insulin lispro-aabc
Insulin,lispro,human/rDNA
Insulin,lispro,protamine/rDNA
Insulina lispro
|
|
7 |
|
Erythromycin |
Approved, Investigational, Vet_approved |
Phase 4 |
|
114-07-8 |
12560 |
Synonyms:
(2R,4S,5R,8R,12R,14R)-11-[(3R,4S,6R)-4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLOXAN-2-YL]OXY-5-ETHYL-3,4,12-TRIHYDROXY-9-[(2R,4R,5S,6S)-5-HYDROXY-4-METHOXY-4,6-DIMETHYLOXAN-2-YL]OXY-2,4,8,10,12,14-HEXAMETHYL-6-OXACYCLOTETRADECANE-1,7-DIONE
(2R,4S,5R,8R,12R,14R)-11-[(3R,4S,6R)-4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYL-OXAN-2-YL]OXY-5-ETHYL-3,4,12-TRIHYDROXY-9-[(2R,4R,5S,6S)-5-HYDROXY-4-METHOXY-4,6-DIMETHYL-OXAN-2-YL]OXY-2,4,8,10,12,14-HEXAMETHYL-6-OXACYCLOTETRADECANE-1,7-DIONE
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(4-DIMETHYLAMINO-3-HYDROXY-6-METHYL-TETRAHYDRO-PYRAN-2-YLOXY)-14-ETHYL-7,12,13-TRIHYDROXY-4-(5-HYDROXY-4-METHOXY-4,6-DIMETHYL-TETRAHYDRO-PYRAN-2-YLOXY)-3,5,7,9,11,13-HEXAMETHYL-OXACYCLOTETRADECANE-2,10-DIONE
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
3''-O-Demethylerythromycin
6-(4-DIMETHYLAMINO-3-HYDROXY-6-METHYL-TETRAHYDRO-PYRAN-2-YLOXY)-14-ETHYL-7,12,13-TRIHYDROXY-4-(5-HYDROXY-4-METHOXY-4,6-DIMETHYL-TETRAHYDRO-PYRAN-2-YLOXY)-3,5,7,9,11,13-HEXAMETHYL-OXACYCLOTETRADECANE-2,10-DIONE(ERYTHROMYCIN)
A/T/S
Abboticin
Abomacetin
Ak-mycin
Akne-mycin
AKNEMYCIN PLUS
Aknin
BENZAMYCIN
Benzamycin Pak
BRISTAMYCIN
C, Erythromycin
C-SOLVE-2
Dotycin
Dumotrycin
E-BASE
E-GLADES
EM
EMGEL
EMU
E-MYCIN
E-Mycin®|EM-A|Erythrocin®|erythromycin-A
Eritrocina
Eritromicina
Ermycin
Erthromycin
ERYACNE 2
ERYACNE 4
Eryc
ERYC 125
ERYC SPRINKLES
Erycen
Erycette
Erycin
Erycinum
ERYDERM
Erygel
Erymax
ERYMAX SPRINKLE
ERYPAR
Ery-Sol
ERY-TAB
ERYTHRA-DERM
Erythro
ERYTHRO 200
ERYTHROCIN
Erythrocin stearate
Erythrogran
Erythroguent
Erythromast 36
Erythromid
ERYTHROMYCIN
Erythromycin a
|
Erythromycin B
Erythromycin C
Erythromycin estolate
Erythromycin ethylsuccinate
Erythromycin glucoheptonate
Erythromycin lactate
Erythromycin lactobionate
Erythromycin oxime
Erythromycin phosphate
Erythromycin stearate
Erythromycine
ÉRYTHROMYCINE
Erythromycinum
ERYTHRO-STATIN
E-SOLVE 2
Ethril 250
ETS
GALLIMYCIN
Ilocaps
Ilosone
Ilotycin
Ilotycin Gluceptate
IndermRetcin
ISOTREXIN
J01FA01
KERYMAX
Kesso-Mycin
Lactate, erythromycin
Mephamycin
NSC-55929
OFTALMOLOSA CUSI ERITROMICINA
PAEDIATHROCIN
Pantomicina
Pce
PFIZER-E
Phosphate, erythromycin
Propiocine
RETCIN
ROBIMYCIN
ROMMIX 250 EC
ROMMIX 500 EC
R-P MYCIN
SANSAC
Serp-AFD
Staticin
STIEMYCIN
T Stat
Taimoxin-F
Theramycin Z
TILORYTH
Torlamicina
TStat
T-Stat
Wemid
WYAMYCIN
Wyamycin S
ZINERYT
|
|
8 |
|
Insulin aspart |
Approved |
Phase 4 |
|
116094-23-6 |
16132418 |
Synonyms:
ASPART
ASPART INSULIN
B28-ASPART-INSULIN
B28-ASP-INSULIN
FIASP
FIASP FLEXTOUCH
FIASP PENFILL
INA-X14
INS NOVORAPID
INSULIN ASPART
Insulin aspart protamine
Insulin aspart protamine recombinant
INSULIN ASPART RECOMBINANT
|
INSULIN X14
INSULIN, ASP(B28)
Insulin, aspart protamine, human
Insulin, aspart, human
Insulin,aspart protamine
Insulina asparta
NOVOLOG
NOVOLOG FLEXPEN
NOVOLOG FLEXTOUCH
NOVOLOG INNOLET
NOVOLOG PENFILL
NOVORAPID
|
|
9 |
|
Hydroxychloroquine |
Approved |
Phase 4 |
|
118-42-3 |
3652 |
Synonyms:
(+-)-Hydroxychloroquine
(±)-HYDROXYCHLOROQUINE
2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol
2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol
7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(N-ethyl-N-b-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(N-ethyl-N-β-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-[4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline
7-Chloro-4-[4-(N-ethyl-N-b-hydroxyethylamino)-1-methylbutylamino]quinoline
7-Chloro-4-[4-(N-ethyl-N-β-hydroxyethylamino)-1-methylbutylamino]quinoline
7-Chloro-4-[5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline
Axemal
DOLQUINE
Dolquine®|Plaquenil®
Ercoquin
Gen-Hydroxychloroquine 200mg Tablets
HCQ
Hidroxicloroquina
|
Hidroxicloroquina [inn-spanish]
Hydroxychlorochin
Hydroxychloroguine
HYDROXYCHLOROQUINE
Hydroxychloroquine sulfate
Hydroxychloroquine sulfate (1:1) salt
Hydroxychloroquinum
Hydroxychloroquinum [inn-latin]
Idrossiclorochina [dcit]
NSC4375
Oxichlorochine
Oxichlorochinum
Oxichloroquine
Oxychlorochin
Oxychloroquine
Plaquenil
Polirreumin
Quensyl
|
|
10 |
|
Metyrapone |
Approved, Investigational |
Phase 4 |
|
54-36-4 |
4174 |
Synonyms:
Alliance brand OF metyrapone
MEO885
Mepyrapone
mepyrapone|Metopirone®
Methapyrapone
Methbipyranone
Methopirapone
Methopyrapone
Methopyrinine
Methopyrone
Metirapona
Metopiron
|
Metopirone
Métopirone
Metroprione
Metyrapon
METYRAPONE
Métyrapone
Metyrapone alliance brand
Metyrapone novartis brand
Metyraponum
Novartis brand OF metyrapone
NSC-25265
|
|
11 |
|
Cyproterone acetate |
Approved, Investigational |
Phase 4 |
|
427-51-0 |
9880 |
Synonyms:
ANDROCUR
ANDROCUR 10
Androcur®|Cyprostat®|SH-714
CYPROSTAT
CYPROSTAT®
CYPROTERONE
|
CYPROTERONE 17-O-ACETATE
CYPROTERONE ACETATE
DIANE
NSC-81430
SH-714
|
|
12 |
|
Tolnaftate |
Approved, Investigational, Vet_approved |
Phase 4 |
|
2398-96-1 |
5510 |
Synonyms:
2-Naphthyl N-methyl-N-(3-tolyl)thionocarbamate
2-Naphthyl N-methyl-N-(3-tolyl)thionocarbamic acid
Aftate
Aftate for athlete's foot gel
Aftate for jock itch aerosol spray powder
Aftate for jock itch gel
Aftate for jock itch sprinkle powder
Bioglan brand OF tolnaftate
Breezee
Carter wallace brand OF tolnaftate
Chinofungin
Chinosol brand OF tolnaftate
Chlorisept
Curatin
Dermoxin
Douglas brand OF tolnaftate
Dr. scholl's athlete's foot spray
Dungistop
Essex brand OF tolnaftate
Focusan
Fungistop
Genaspor
Genaspore cream
Hi-alarzin
Hi-alazin
Insight brand OF tolnaftate
Isdin brand OF tolnaftate
m,N-Dimethylthiocarbanilate O-2-naphthyl ester
m,N-Dimethylthiocarbanilic acid O-2-naphthyl ester
Methyl (3-methylphenyl)carbamothioate O-2-naphthalenyl ester
Methyl (3-methylphenyl)carbamothioic acid O-2-naphthalenyl ester
Micoisdin
MYCIL
Naphthiomate T
Naphthiomate-T
N-Methyl-N-(3-methylphenyl)-1-(naphthalen-2-yloxy)methanethioamide
NP 27
NP-27
NP-27 Cream
NP-27 Powder
NP-27 Solution
NP-27 Spray powder
NSC-233648
O-2-Naphthyl m,N-dimethylthiocarbanilate
O-2-Naphthyl m,N-dimethylthiocarbanilic acid
Ony clear
Ony-clear
Pedinol brand 1 OF tolnaftate
Pedinol brand 2 OF tolnaftate
Phytoderm
Pitrex
Pitrex cream
Prestwick_472
|
Purder N, tolnaftat
SCH-10144
Schering brand OF tolnaftate
Schering-plough brand 1 OF tolnaftate
Schering-plough brand 2 OF tolnaftate
Separin
Sorgoa
Sporiline
Stiefel brand OF tolnaftate
Thompson brand OF tolnaftate
Timoped
Tinactin
Tinactin aerosol liquid
Tinactin aerosol powder
Tinactin antifungal deodorant powder aerosol
Tinactin cream
Tinactin jock itch aerosol powder
Tinactin jock itch cream
Tinactin jock itch spray powder
Tinactin plus aerosol powder
Tinactin plus powder
Tinactin powder
Tinactin solution
Tinaderm
TINADERM PLUS
Tinatox
Tinavet
Tineafax
Ting
Ting antifungal cream
Ting antifungal powder
Ting antifungal spray liquid
Ting antifungal spray powder
Ting products
Tniaderm
Tolnaftat purder N
TOLNAFTATE
Tolnaftate douglas brand
Tolnaftate schering brand
Tolnaftato
Tolnaftatum
Tolnaftic acid
Tolnaphthate
Tolnaphthic acid
Tolsanil
Tonoftal
Tritin
Wernigerode brand OF tolnaftate
ZeaSorb
Zeasorb-af
Zeasorb-af powder
Zenith brand OF tolnaftate
|
|
13 |
|
Phentermine |
Approved, Illicit |
Phase 4 |
|
122-09-8 |
4771 |
Synonyms:
(alpha,alpha)-Dimethylphenethylamine
a,a-Dimethylphenethylamine
Adipex p
Adipex-p
AdipexP
alpha,alpha-Dimethylphenethylamine
Duromine
Fentermina
Hydrochloride, phentermine
|
IONAMIN
Ionamine
PHENTERMINE
Phentermine hydrochloride
PHENTERMINE RESIN
PHENTERMINE RESIN 30
PHENTERMINE RESIN COMPLEX
Phenterminum
Α,α-dimethylphenethylamine
|
|
14 |
|
Rosiglitazone |
Approved, Investigational |
Phase 4 |
|
122320-73-4, 155141-29-0 |
77999 |
Synonyms:
(±)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione
(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion
5-((4-(2-(Methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate
AVANDAMET
AVANDARYL
Avandia
Avandia®|rosiglizole
BRL-49653
BRL-49653C
BRL-49653-C
Gaudil
|
Glaxo wellcome brand OF rosiglitazone maleate
GlaxoSmithKline brand OF rosiglitazone maleate
Rosigliazone maleate
Rosiglitazon
Rosiglitazona
Rosiglitazone
Rosiglitazone maleate
Rosiglitazonum
Rosiglizole
SmithKline beecham brand OF rosiglitazone maleate
TDZ-01
|
|
15 |
|
Coal tar |
Approved |
Phase 4 |
|
8007-45-2 |
|
Synonyms:
|
16 |
|
Loperamide |
Approved |
Phase 4 |
|
53179-11-6 |
3955 |
Synonyms:
Apo-loperamide
Diamide
FORTASEC
Fortasec®|Imodium®|R-18553
Hydrochloride, loperamide
Imodium
Imodium a-D
Imodium a-D caplets
Kaopectate II
Loperacap
Loperamid
Loperamida
|
Loperamide
Lopéramide
Loperamide hydrochloride
Loperamide monohydrochloride
Loperamidum
Maalox anti-diarrheal
Monohydrochloride, loperamide
Nu-loperamide
PMS-Loperamide
R-18553
Rho-loperamide
|
|
17 |
|
Heparin, bovine |
Approved, Investigational, Withdrawn |
Phase 4 |
|
9005-49-6 |
22833565 9812414 772 |
Synonyms:
Adomiparin
alpha-Heparin
Ariven
Arteven
Bemiparin
BOVINE HEPARIN
Calcilean
CALCIPARINE
Certoparin
CLEXANE
Clexane®|enoxaparin sodium|Lovenox®|PK-10169|RP-54563
Clivarin
Clivarine
DALTEPARIININATRIUM
Dalteparin
DALTEPARIN SODIUM
dalteparin sodium|Fragmin®
DALTEPARIN SODNÁ SŮL
DALTEPARIN SODYUM
DALTEPARINA SODICA
DALTEPARINA SÓDICA
DALTEPARINE SODIQUE
DALTÉPARINE SODIQUE
DALTEPARINNATRIUM
DALTEPARIN-NATRIUM
DALTEPARIN-NÁTRIUM
DALTEPARINO NATRIO DRUSKA
DALTEPARINUM NATRICUM
DALTEPARYNA SODOWA
Depo-Heparin
ENOXAPARIN
ENOXAPARIN SODIUM
ENOXAPARIN SODIUM (PRESERVATIVE FREE)
ENOXAPARIN SODIUM SALT
Eparina
Eparina [DCIT]
Fluxum
FR-860
FRAGMIN
Fragmin A
Fragmin B
Fraxiparin
Hed-Heparin
Hepalean
HEPARIN
Heparin Cy 216
|
HEPARIN FRAGMENT KABI 2165
Heparin Leo
Heparin Lock Flush
HEPARIN SODIUM
Heparin sodium preservative Free
Heparin sodium salt
Heparin sulfate
Heparin sulphate
Heparina
HEPARINATE
Heparine
HEPARINIC ACID
Heparinsodiumsalt
Heparinum
Hepathrom
HepFlush®
HEP-LOCK
KABI-2165
Leparan
Lipo-Hepin
LIQUAEMIN
Liquaemin Sodium
Liquemin
LOVENOX
LOVENOX (PRESERVATIVE FREE)
LOW LIQUEMINE
Low molecular weight heparin sodium
Multiparin
Novoheparin
Pabyrin
PANHEPRIN
Parnaparin
Parnaparin sodium
Parvoparin
PK-10169
Pularin
Reviparin
RP-54563
Sandoparin
SODIUM HEPARIN
Sublingula
TEDELPARIN
Thromboliquine
Unfractionated heparin
Vetren
Vitrum AB
|
|
18 |
|
Rocuronium |
Approved |
Phase 4 |
|
119302-91-9, 143558-00-3 |
441290 |
Synonyms:
1-(17-(Acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium
Esmeron
Esmerone
ORG-9426
Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, bromide
|
Rocuronio
ROCURONIUM
Rocuronium bromide
Zemuron
|
|
19 |
|
Levoleucovorin |
Approved, Experimental, Investigational |
Phase 4 |
|
68538-85-2, 58-05-9, 73951-54-9 |
149436 6006 |
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R)-Leucovorin
(6R,2'S)-Folinic acid
(6R,S)-5-Formyltetrahydrofolate
(6S)-5-Formyl-5,6,7,8-tetrahydrofolate
(6S)-5-FORMYL-5,6,7,8-TETRAHYDROFOLIC ACID
(6S)-5-Formyltetrahydrofolate
(6S)-5-FORMYLTETRAHYDROFOLIC ACID
(6S)-Folinate
(6S)-FOLINIC ACID
(6S)-LEUCOVORIN
(S)-LEUCOVORIN
[6R]-5-formyl-5,6,7,8-tetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5 Formyltetrahydrofolate
5 Formyltetrahydropteroylglutamate
5-Formlyl-5,6,7,8-tetrahydrofolate,calcium salt
5-Formyl-(6S)-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formylTHF
6 S Leucovorin
6R-Leucovorin
6S Leucovorin
6S-Leucovorin
6-S-Leucovorin
Acid, folinic
Acide folinique
Acido folinico
ácido levofolínico
Calcium citrovorum factor
Calcium folinate
Calcium leucovorin
CF
Citrovorum factor
Dextrofolinic acid
Factor, citrovorum
Folinate
Folinate, calcium
Folinic acid
Folinic acid calcium salt
Folinic acid calcium salt USP27
Folinic acid SF
Folinic acid-SF
FUSILEV
KHAPZORY
|
Kunyrin
L(-)-5-Formyl-5,6,7,8-tetrahydrofolate
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
Leucal
Leucoverin
Leucovorin
Leucovorin calcium
Leucovorin folinic acid
Leucovorin, (D)-isomer
Leucovorin, (DL)-isomer
Leucovorin, (R)-isomer
Leucovorin, (S)-isomer
Leucovorin, calcium
Leucovorin, calcium (1:1) salt
Leucovorin, calcium (1:1) salt, (DL)-isomer
Leucovorin, calcium (1:1) salt, (S)-isomer
Leucovorin, calcium (1:1) salt, pentahydrate
Leucovorin, monopotassium salt, (S)-isomer
Leucovorin, monosodium salt
Leucovorin, monosodium salt, (S)-isomer
Leucovorinum
Leukovorin
Leukovorum
Levo leucovorin
LEVOFOLENE
Levofolinate
LEVOFOLINIC ACID
Levoleucovorin
Levo-leucovorin
L-Folinate
L-FOLINIC ACID
LFP-754
L-Leucovorin
L-N-[P-[[(2-amino-5-Formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-glutamic acid
Monosodium salt leucovorin
N(5)-Formyltetrahydrofolate
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamate
N-[4-({[(6S)-2-AMINO-5-FORMYL-4-OXO-1,4,5,6,7,8-HEXAHYDROPTERIDIN-6-YL]METHYL}AMINO)BENZOYL]-L-GLUTAMIC ACID
N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
N5-Formyl-THF
Pteroyl-D-glutamate
Rescuvolin
S Leucovorin
S-Leucovorin
Welcovorin
Wellcovorin
|
|
20 |
|
Calcium carbonate |
Approved, Investigational |
Phase 4 |
|
471-34-1 |
|
Synonyms:
Aragonite
CaCO3
Calcio carbonato
Calcite
Calcium carbonate
Calcium carbonate (1:1)
Calcium carbonate, precipitated
Calcium carbonic acid
Calcium carbonic acid (1:1)
Calcium carbonic acid, precipitated
Calcium milk
Calciumcarbonat
Cal-sup
Carbonate calcium salt (1:1)
Carbonate de calcium
|
Carbonate, calcium
Carbonato de calcio
Carbonic acid calcium salt (1:1)
Carbonic acid de calcium
Chalk
e 170
Kalziumkarbonat
Kohlensaurer kalk
Limestone
Marble
Milk OF calcium
Precipitated calcium carbonate
Precipitated calcium carbonic acid
Vaterite
|
|
21 |
|
Ursodeoxycholic acid |
Approved, Investigational |
Phase 4 |
|
128-13-2 |
31401 |
Synonyms:
(3a,5b,7b)-3,7-Dihydroxycholan-24-Oate
(3a,5b,7b)-3,7-Dihydroxy-cholan-24-Oate
(3a,5b,7b)-3,7-Dihydroxycholan-24-Oic acid
(3a,5b,7b)-3,7-Dihydroxy-cholan-24-Oic acid
(3alpha,5beta,7beta)-3,7-Dihydroxycholan-24-Oate
(3alpha,5beta,7beta)-3,7-Dihydroxycholan-24-Oic acid
(3Α,5β,7β)-3,7-dihydroxycholan-24-Oate
(3Α,5β,7β)-3,7-dihydroxycholan-24-Oic acid
(4R)-4-[(1S,2S,5R,7S,9S,10R,11S,14R,15R)-5,9-DIHYDROXY-2,15-DIMETHYLTETRACYCLO[8.7.0.0?,?.0??,??]HEPTADECAN-14-YL]PENTANOIC ACID
3 alpha,7 beta Dihydroxy 5 beta cholan 24 Oic acid
3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-Oic acid
3,7-Dihydroxycholan-24-Oic acid
3a,7b-Dihydroxy-5b-cholan-24-Oate
3a,7b-Dihydroxy-5b-cholan-24-Oic acid
3alpha,7beta-Dihydroxy-5beta-cholan-24-Oate
3alpha,7beta-Dihydroxy-5beta-cholan-24-Oic acid
3-alpha,7-beta-Dihydroxy-5-beta-cholanoic acid
3-alpha,7-beta-Dihydroxycholanic acid
3-alpha,7-beta-Dioxycholanic acid
3Α,7β-dihydroxy-5β-cholan-24-Oate
3Α,7β-dihydroxy-5β-cholan-24-Oic acid
ACG240
Acid, deoxyursocholic
Acid, ursacholic
Acid, ursodeoxycholic
Acide ursodesoxycholique
Acido ursodeossicolico
Acido ursodeoxicolico
Acidum ursodeoxycholicum
Actigall
Antigall
Antigen brand OF ursodeoxycholic acid
Aventis brand OF ursodeoxycholic acid
Axcan brand OF ursodeoxycholic acid
Cholit-ursan
Cholofalk
CHOLURSO
CP Brand OF ursodeoxycholic acid
Delursan
Deoxyursocholic acid
|
Destolit
Estedi brand OF ursodeoxycholic acid
Falk brand OF ursodeoxycholic acid
Farmasa brand OF ursodeoxycholic acid
Galen brand OF ursodeoxycholic acid
Heumann brand OF ursodeoxycholic acid
Niddapharm brand OF ursodeoxycholic acid
Norgine brand OF ursodeoxycholic acid
NSC-683769
Orphan brand OF ursodeoxycholic acid
Provalis brand OF ursodeoxycholic acid
Sanofi synthelabo brand OF ursodeoxycholic acid
Sodium ursodeoxycholate
Tramedico brand OF ursodeoxycholic acid
UDCA
Urdox
Urosdesoxycholate
Urosdesoxycholic acid
Ursacholic acid
Urso
URSO 250
URSO FORTE
Urso heumann
Ursobilane
Ursochol
Ursodeoxycholate
Ursodeoxycholate, sodium
URSODEOXYCHOLIC ACID
Ursodeoxycholicacid
URSODESOXYCHOLIC ACID
Ursodexycholate
Ursodexycholic acid
Ursodiol
Ursofalk
Ursogal
Ursolite
Ursolvan
Vita brand OF ursodeoxycholic acid
Zambon brand OF ursodeoxycholic acid
|
|
22 |
|
Tomato |
Approved |
Phase 4 |
|
|
|
23 |
|
Dapagliflozin |
Approved |
Phase 4 |
|
461432-26-8 |
9887712 |
Synonyms:
(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
BMS-512148
BMS-512148|Farxiga®|Forxiga®
BMS-512148-05
|
Dapagliflozin
Dapagliflozina
FARXIGA
FORXIGA
|
|
24 |
|
Infliximab |
Approved |
Phase 4 |
|
170277-31-3 |
|
Synonyms:
ABP 710
BOW015
CA2
CA2 ????
IG GAMMA-1 CHAIN C REGION
INFLECTRA
INFLIXIMAB
Infliximab (genetical recombination)
|
Infliximab-abda
Infliximab-axxq
Infliximab-dyyb
Infliximab-qbtx
NI-071
REMICADE
REMSIMA
TA-650
|
|
25 |
|
Octreotide |
Approved, Investigational |
Phase 4 |
|
83150-76-9 |
383414 6400441 |
Synonyms:
(4R,7S,10S,13R,16S,19R)-19-{[(2R)-2-amino-1-hydroxy-3-phenylpropylidene]amino}-10-(4-aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-6,9,12,15,18-pentahydroxy-7-(1-hydroxyethyl)-13-[(1H-indol-3-yl)methyl]-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaene-4-carboximidate
19-[(2-Amino-1-hydroxy-3-phenylpropylidene)amino]-10-(4-aminobutyl)-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-6,9,12,15,18-pentahydroxy-7-(1-hydroxyethyl)-13-[(1H-indol-3-yl)methyl]-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaene-4-carboximidate
Compound 201 995
Compound 201995
Compound 201-995
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L- threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L- cysteinamide cyclic (2->7)-disulfide
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L- threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L- cysteinamide cyclic (2->7)-disulphide
DRG-0115|Mycapssa®|Sandostatin®|SMS 201,995
Octreotida
Octreotide
Octreotide acetate
OCTREOTIDE ACETATE (PRESERVATIVE FREE)
OCTREOTIDE ACETATE PRESERVATIVE FREE
Octreotide acetate salt
Octreotidum
|
Octrotide
Sandostatin
SANDOSTATIN LAR
Sandostatine
Sandoz 201 995
Sandoz 201995
Sandoz 201-995
SMS 201-995
SMS 201-995 AC
SMS-201-995
SMS-201-995 AC
SMS-201995-AC
SMS995
SMS-995
|
|
26 |
|
Saxagliptin |
Approved |
Phase 4 |
|
361442-04-8 |
11243969 |
Synonyms:
(1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile
3-Hydroxyadamantylglycine-4,5-methanoprolinenitrile hydrate
BMS 477118
BMS-477118
BMS-477118|Onglyza®
|
BMS-477118-11
Onglyza
SAXAGLIPTIN
SAXAGLIPTIN ANHYDROUS
Saxagliptina
|
|
27 |
|
Ethinylestradiol |
Approved |
Phase 4 |
|
57-63-6 |
5991 |
Synonyms:
(1S,10R,11S,14R,15S)-14-ETHYNYL-15-METHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADECA-2,4,6-TRIENE-5,14-DIOL
17 ALPHA-ETHINYLESTRADIOL
17 ALPHA-ETHYNYLESTRADIOL
17 ALPHA-ETHYNYLOESTRADIOL
17α-ethynylestradiol|ethinyl estradiol
17a-Ethinyl estradiol
17a-Ethinyl-17b-estradiol
17a-Ethinylestradiol
17a-Ethynyl-17b-oestradiol
17a-Ethynylestradiol-L7b
17a-Ethynyloestradiol
17a-Ethynyloestradiol-17b
17alpha-Ethinyl estradiol
17-Ethinyl-3,17-estradiol
17-Ethinyl-3,17-oestradiol
17-Ethinylestradiol
17-Ethynylestradiol
17-Ethynylestradiol ram
17-Ethynyloestradiol
17Α-ethinyl estradiol
17Α-ETHYNYLESTRADIOL
Alora
Amenoron
Anovlar
Chee-O-gen
Chee-O-genf
Diognat-e
Diogyn e
Diogyn-e
Dyloform
Effik brand OF ethinyl estradiol
ENOVID
ENOVID-E
Ertonyl
Esclim
Esteed
Estigyn
Estinyl
Eston-e
Estoral
Estoral {[orion]}
Estorals
Estradiol, ethinyl
Estradiol, ethynyl
Estring
Estrogen
Ethidol
Ethinoral
Ethinyl estradiol
Ethinyl estradiol hemihydrate
Ethinyl estradiol, (8 alpha)-isomer
Ethinyl estradiol, (8 alpha,17 alpha)-isomer
Ethinyl estradiol, (8 alpha,9 beta,13 alpha,14 beta)-isomer
Ethinyl estradiol, (9 beta,17 alpha)-isomer
Ethinyl oestradiol effik
Ethinylestradiol
Ethinylestradiol jenapharm
ETHINYLESTRADIOLUM
Ethinylestriol
Ethinyloestradiol
|
Ethinyl-oestradiol effik
ETHINYL-OESTRANOL
Ethynyl estradiol
Ethynylestradiol
ETHYNYLOESTRADIOL
Eticyclin
Eticyclol
Eticylol
Etinestrol
Etinestryl
ETINILESTRADIOL
Etinoestryl
Etistradiol
Etivex
Feminone
Fempatch
Follicoral
Ginestrene
Gynodiol
Gynolett
Hemihydrate, ethinyl estradiol
Inestra
Innofem
Jenapharm brand OF ethinyl estradiol
Jenapharm, ethinylestradiol
Kolpolyn
Linoral
Lynoral
Menolyn
Menostar
Microfollin
Microfollin forte
Neo-estrone
Nogest-S
NORINYL
Novestrol
NSC-10973
Oradiol
Orestralyn
Orestrayln
Organon brand OF ethinyl estradiol
Ovex
OVULEN
OVULEN-21
OVULEN-28
Palonyl
Perovex
Primogyn
Primogyn C
Primogyn m
Progynon C
Progynon m
Schering brand OF ethinyl estradiol
Schering-plough brand OF ethinyl estradiol
Spanestrin
Thiuram e
Thiuranide
Vagifem
Ylestrol
|
|
28 |
|
Norgestimate |
Approved, Investigational |
Phase 4 |
|
35189-28-7 |
6540478 |
Synonyms:
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetic acid (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one oxime acetate (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one oxime acetic acid (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one oxime acetate (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one oxime acetic acid (ester)
(17a)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
(17Α)-17-(acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime
D-13b-Ethyl-17a-ethynyl-17b-acetoxygon-4-en-3-one oxime
|
D-13Β-ethyl-17α-ethynyl-17β-acetoxygon-4-en-3-one oxime
DEXNORGESTREL
Dexnorgestrel acetime
dexnorgestrel|ORF-10131|RWJ-10131
NORGESTIMATE
Norgestimato
Norgestimatum
Norgestimic acid
Norgestrel oxime acetate
ORF-10131
RWJ-10131
|
|
29 |
|
Moxifloxacin |
Approved, Investigational |
Phase 4 |
|
186826-86-8, 354812-41-2, 151096-09-2 |
152946 |
Synonyms:
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylate
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid
1-Cyclopropyl--7-(2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
Actira
Avalox
Avelox
AVELOX I.V.
BAY 12-8039
|
Izilox
MOXIFLOXACIN
Moxifloxacin HCl
Moxifloxacin hydrochloride
Moxifloxacino
Octegra
Proflox
VIGAMOX
|
|
30 |
|
Desflurane |
Approved |
Phase 4 |
|
57041-67-5 |
42113 |
Synonyms:
(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether
(±)-2-difluoromethyl 1,2,2,2-tetrafluoroethyl ether
1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane
1,2,2,2-Tetrafluoroethyl difluoromethyl ether
Baxter anaesthesia brand OF desflurane
Baxter brand OF desflurane
DESFLURANE
DESFLURANO
Desflurano [INN-Spanish]
|
DESFLURANUM
Desfluranum [INN-Latin]
Difluoromethyl 1,2,2,2-tetrafluoroethyl ether
HFE-236EA2
I-653
Ohmeda brand OF desflurane
Suprane
Zeneca brand OF desflurane
|
|
31 |
|
Zonisamide |
Approved, Investigational |
Phase 4 |
|
68291-97-4 |
5734 |
Synonyms:
1,2-Benzisoxazole-3-methanesulfonamide
1,2-Benzisoxazole-3-methanesulphonamide
3 Sulfamoylmethyl 1,2 benzisoxazole
3-(Sulfamoylmethyl)-1,2-benzisoxazole
3-(Sulphamoylmethyl)-1,2-benzisoxazole
3-Sulfamoylmethyl-1,2-benzisoxazole
AD-810
AD-810|CI-912|PD-110843|Zonegran®
Benzo[D]isoxazol-3-yl-methanesulfonamide
Benzo[D]isoxazol-3-yl-methanesulphonamide
CI-912
Elan brand OF zonisamide
|
Exceglan
Excegram
Excegran
PD-110843
Zonegran
Zonisamida
Zonisamida [Spanish]
Zonisamide
Zonisamide monosodium
Zonisamidum
Zonisamidum [Latin]
|
|
32 |
|
Apixaban |
Approved |
Phase 4 |
|
503612-47-3 |
10182969 |
Synonyms:
APIXABAN
APIXABÁN
Apixabanum
BMS 562247-01
|
BMS-562247
BMS-562247|Eliquis®
BMS-562247-01
Eliquis
|
|
33 |
|
Parathyroid hormone |
Approved, Investigational |
Phase 4 |
|
9002-64-6 |
|
Synonyms:
ALX1-11
ALX-111
ALX-1-11
NPSP558
NPSP-558
Parathormone
Parathormone (human recombinant)
Parathyrin
PARATHYROID HORMONE
Parathyroid hormone (1-84) human recombinant
|
Parathyroid hormone (rDNA)
PAROIDIN
PREOTACT
PTH
PTH(1-84)
rhPTH
rhPTH(1-84)
rPTH
rPTH(1-84)
|
|
34 |
|
Orange |
Approved |
Phase 4 |
|
|
|
35 |
|
Drospirenone |
Approved |
Phase 4 |
|
67392-87-4 |
68873 |
Synonyms:
1,2-Dihydrospirorenone
1,2-Dihydro-spirorenone
15b,16b-dimethylene-3-oxo-17a-pregn-4-ene-21,17-carbolactone
15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone
15β,16β-dimethylene-3-oxo-17α-pregn-4-ene-21,17-carbolactone
6b,7Beta
6beta,7Beta
6beta,7beta,15beta,16beta-Dimethylen-3-oxo-17alpha-pregn-4-en-21,17-carbolacton
6BETA,7BETA;15BETA,16BETA-DIMETHYLENE-3-OXO-17ALPHA-PREGN-4-ENE-21,17-CARBOLACTONE
6Β,7beta
6β,7β
6Β,7β,15β,16β-dimethylene-3-oxo-17α-pregn-4-ene-21,17 carbolactone
ANGELIQ
|
Dehydrospirorenone
Dihydrospirorenone
dihydrospirorenone|Slynd®|Yasmin®|ZK30595
Drospirenona
DROSPIRENONE
Drospirénone
Drospirenonum
DRSP
Slynd
YASMIN
ZK30595
ZK-30595
|
|
36 |
|
Glyburide |
Approved |
Phase 4 |
|
10238-21-8 |
3488 |
Synonyms:
1-((p-(2-(5-Chloro-O-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea
1-((p-(2-(5-Chloro-O-anisamido)ethyl)phenyl)sulphonyl)-3-cyclohexylurea
1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea
1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulphonyl)-3-cyclohexylurea
5-Chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide
5-Chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulphonyl)phenyl)ethyl)-2-methoxybenzamide
Abbenclamide
Adiab
Amglidia®|Diabeta®|glyburide|Glynase®
Apo-glibenclamide
Azuglucon
Bastiverit
Benclamin
Betanase
Betanese 5
CALABREN
Cytagon
Daonil
Debtan
Dia-basan
Diabeta
DIABETAMIDE 2.5
DIABETAMIDE 5
Diabiphage
Dibelet
Duraglucon
Euclamin
Euglucan
EUGLUCON
Euglucon 5
Euglucon N
Euglykon
GBN 5
Gen-Glybe
Gewaglucon
Gilemal
Glamide
Glibadone
Gliban
Gliben
Glibenbeta
Glibenclamid AL
Glibenclamid Basics
Glibenclamid Fabra
Glibenclamid Genericon
Glibenclamid Heumann
Glibenclamid Riker M.
Glibenclamida
Glibenclamida [INN-Spanish]
Glibenclamid-Cophar
Glibenclamide
Glibenclamid-Ratiopharm
Glibenclamidum
Glibenclamidum [INN-Latin]
Glibenil
Gliben-Puren N
Glibens
Glibesyn
Glibet
Glibetic
|
Glibil
Gliboral
Glicem
Glidiabet
GLIKEN
Glimel
Glimide
Glimidstata
Glisulin
Glitisol
Glubate
Gluben
Glucobene
Glucohexal
Glucolon
Glucomid
Glucoremed
Gluco-Tablimen
Glucoven
Glyben
Glybenclamide
Glybenzcyclamide
GLYBURIDE
GLYBURIDE (MICRONIZED)
Glycolande
Glycomin
Glynase
GLYNASE PRESTAB
HB 419
HB-419
Hexaglucon
Humedia
LEDERGLIB
LIBANIL
Lisaglucon
MALIX
Maninil
Med-Glionil
Melix
Micronase
Miglucan
Nadib
Neogluconin
Norglicem 5
Normoglucon
Novo-Glyburide
Orabetic
Pira
Praeciglucon
PresTab
Prodiabet
Renabetic
SEMI-DAONIL
Sugril
Suraben
Tiabet
U-26,45
U-26452
Yuglucon
|
|
37 |
|
Atorvastatin |
Approved |
Phase 4 |
|
134523-00-5 |
60823 |
Synonyms:
(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid
(3R,5R)-7-[2-(4-FLUOROPHENYL)-3-PHENYL-4-(PHENYLCARBAMOYL)-5-(PROPAN-2-YL)-1H-PYRROL-1-YL]-3,5-DIHYDROXYHEPTANOIC ACID
(R-(R*,r*))-2-(4-fluorophenyl)-b,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-b,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-b,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-b,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
7-[2-(4-FLUORO-phenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-3,5-dihydroxy-heptanoate
7-[2-(4-FLUORO-phenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-3,5-dihydroxy-heptanoIC ACID
Anhydrous, atorvastatin calcium
Atogal
Atorlip
Atorpic
ATORVASTATIN
Atorvastatin acid
Atorvastatin calcium
Atorvastatin calcium anhydrous
Atorvastatin calcium hydrate
Atorvastatin calcium trihydrate
Atorvastatin, calcium salt
Atorvastatina
Atorvastatine
Atorvastatinum
Calcium anhydrous, atorvastatin
Calcium hydrate, atorvastatin
Calcium salt atorvastatin
Calcium trihydrate, atorvastatin
Calcium, atorvastatin
|
Cardyl
Faboxim
Hipolixan
Hydrate, atorvastatin calcium
LCF872
Lipitor
Lipitor®
Lipotropic
Lipovastatinklonal
Liprimar
Liptonorm
Lowden
Normalip
PREVENCOR
Sincol
Sortis
Sotis
TAHOR
Torvacard
Torvast
Totalip
Tozalip
Trihydrate, atorvastatin calcium
Tulip
Vastina
Xanator
Xarator
Xavator
ZARATOR
Zurinel
|
|
38 |
|
Risedronic acid |
Approved, Investigational |
Phase 4 |
|
105462-24-6 |
5245 |
Synonyms:
1-Hydroxy-2-(3-pyridyl)ethylidene diphosphonate
2-(3-Pyridinyl)-1-hydroxyethylidenebisphosphonate
2-(3-Pyridinyl)-1-hydroxyethylidene-bisphosphonate
Acid, risedronic
Acide risédroniqe
Acido risedronico
Acidum risedronicum
Actonel
Actonel 150
Actonel®|Atelvia®|NE-58095|risedronate sodium
Atelvia
Benet
Bisphosphate risedronate sodium
Bisphosphonate risedronate sodium
|
M05BA07
NE-58095
Ridron
Risedronate
Risedronate sodium
Risedronate sodium, bisphosphate
Risedronate sodium, bisphosphonate
Risedronic acid
Risedronic acid, monosodium salt
Risedronsäure
Sodium, bisphosphate risedronate
Sodium, bisphosphonate risedronate
Sodium, risedronate
|
|
39 |
|
Memantine |
Approved, Investigational |
Phase 4 |
|
41100-52-1, 19982-08-2 |
4054 |
Synonyms:
1,3-Dimethyl-5-adamantanamine
1,3-Dimethyl-5-aminoadamantane
1,3-DIMETHYLAMINOADAMANTANE
1-Amino-3,5-dimethyladamantane
3,5-Dimethyl-1-adamantanamine
3,5-Dimethyl-1-aminoadamantane
3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine
AKATINOL
Axura
Axura®|Ebixa®|Namenda®
D-145
DMAA
DRG-0267
Ebixa
Exiba
FP-01
Lundbeck brand OF memantine hydrochloride
|
MARIXINO
Memantin
Memantina
Memantina [INN-Spanish]
MEMANTINE
Memantine [INN]
MEMANTINE HCL
Memantine hydrochloride
Memantinum
Memantinum [INN-Latin]
Merz brand OF memantine hydrochloride
Namenda
NAMENDA XR
NEMDATINE
NSC-102290
SUN-Y7017
VALIOS
|
|
40 |
|
Cyclophosphamide |
Approved, Investigational |
Phase 4 |
|
50-18-0, 6055-19-2 |
2907 |
Synonyms:
(+-)-Cyclophosphamide
(+,-)-2-(Bis(2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide monohydrate
(RS)-Cyclophosphamide
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
Anhydrous cyclophosphamide
Anhydrous, cyclophosphamide
ASTA
Asta B 518
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
Ciclofosfamida
Ciclofosfamide
Clafen
Claphene
CP
CPA
CTX
CY
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide anhydrous
Cyclophosphamide monohydrate
Cyclophosphamide Sterile
Cyclophosphamide, (R)-isomer
Cyclophosphamide, (S)-isomer
Cyclophosphamidum
Cyclophosphan
Cyclophosphane
Cyclophosphoramide
|
Cyclostin
Cyklofosfamid
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan Lyoph
Endoxan
Endoxan R
Endoxana
Endoxanal
Endoxan-Asta
Endoxane
Enduxan
Genoxal
Hexadrin
LEDOXINA
Lyophilized Cytoxan
Mitoxan
Monohydrate, cyclophosphamide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
Neosar
Procytox
Rcra Waste Number U058
Revimmune
Semdoxan
Sendoxan
Senduxan
Zyklophosphamid
|
|
41 |
|
Letrozole |
Approved, Investigational |
Phase 4 |
|
112809-51-5 |
3902 |
Synonyms:
4,4'-(1H-1,2,4-Triazol-1-yl-methylene)-bis(benzonitrile)
CGS-20267
FEM345
Femara
Fémara
|
Femara®
Letrozol
LETROZOLE
Novartis brand OF letrozole
|
|
42 |
|
Galantamine |
Approved |
Phase 4 |
|
357-70-0, 1953-04-4 |
9651 |
Synonyms:
(-)-GALANTHAMINE
ACUMOR XL
CONSION XL
ELMINO XL
Galantamin
Galantamina
Galantamine
Galanthamine
Galanthamine hydrobromide
galanthamine|Razadyne®
GALSYA XL
GALZEMIC XL
GATALIN XL
GAZYLAN XL
|
Jilkon
LOTPROSIN XL
LUVENTA XL
Lycoremin
Lycoremine
Nivalin
Nivaline
NSC-100058
Ortho mcneil neurologics brand OF galantamine
Ortho-mcneil neurologics brand OF galantamine
Razadyne
Reminyl
REMINYL XL
ZEEBRAL XL
|
|
43 |
|
Amoxicillin |
Approved, Vet_approved |
Phase 4 |
|
26787-78-0 |
33613 |
Synonyms:
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(p-Hydroxy-a-aminophenylacetamido)penicillanate
6-(p-Hydroxy-a-aminophenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanate
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-Hydroxy-α-aminophenylacetamido)penicillanate
6-(p-Hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9ci
a-Amino-p-hydroxybenzylpenicillin
Actimoxi
Almodan
alpha-Amino-p-hydroxybenzylpenicillin
AMC
Amix
AMIX 125
AMIX 250
AMIX 500
Amoclen
Amolin
Amopen
Amopenixin
Amoram
AMOX
Amox 250 cap 250MG
Amox 500 cap 500MG
Amox S 125 sus 125mg/5ML
Amox S 250 sus 250mg/5ML
Amoxi
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin
Amoxicillin (anhydrous)
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin clariana brand
AMOXICILLIN HYDRATE
Amoxicillin monopotassium salt
Amoxicillin monosodium salt
Amoxicillin pediatric
Amoxicillin sodium
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicillin, (r*)-isomer
Amoxicilline
Amoxicilline [INN-French]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
AMOXIDENT 250
AMOXIDENT 500
AMOXI-INJECT
Amoxil
AMOXIL FIZTAB
AMOXIL SF
Amoxi-mast
AMOXI-TABS
Amoxivet
Amoxycilin
Amoxycillin
AMOXYCILLIN ANHYDROUS
Amoxycillin trihydrate
Amoxycillin, ban
Amoxymed
AMPC
Amrit
Anemolin
Anhydrous, amoxicillin
Apo-amoxi
Apo-amoxi cap 250MG
Apo-amoxi cap 500MG
Apo-amoxi PWR for susp 125mg/5ML
Apo-amoxi PWR for susp 250mg/5ML
Apo-amoxi sugar free
AQUACIL
Aspenil
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
|
AUGMENTIN '875'
AUGMENTIN es-600
AX
Biomox
Bristamox
BRL 2333
BRL-2333
Cemoxin
Clamoxyl
Clamoxyl (SKB)
Clamoxyl g.a.
Clamoxyl parenteral
Clariana brand OF amoxicillin
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
DEDOXIL
Delacillin
Dispermox
Efpenix
Flemoxin
FLEMOXIN SOLUTAB
G.A., clamoxyl
Galenamox
Gen-amoxicillin 250MG
Gen-amoxicillin 500MG
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
Lamoxy
Larotid
Metafarma capsules
Metifarma capsules
Moxacin
Moxal
Moxatag
Novamoxin cap 250MG
Novamoxin cap 500MG
Novamoxin sus 125mg/5ML
Novamoxin sus 250mg/5ML
NSC-277174
Nu-amoxi cap 250MG
Nu-amoxi cap 500MG
Nu-amoxi sus 125/5ML
Nu-amoxi sus 250mg/5ML
Ospamox
Pamoxicillin
Parenteral, clamoxyl
Penamox
Pfizer brand OF amoxicillin sodium salt
PHL-Amoxicillin
p-Hydroxyampicillin
Piramox
PMS-Amoxicillin
Polymox
Prevpac
Pro amox PWR for oral susp 125mg/5ML
Pro amox-250 cap 250MG
Pro amox-500 cap 500MG
Pro-amox-250 orl sus 250mg/5ML
RESPILLIN
R-Hydroxyampicillin
Rimoxallin
Robamox
Sauracillin
Sawamox PM
SmithKline beecham brand OF amoxicillin sodium salt
Sodium, amoxicillin
Sumox
Tolodina
Trihydrate, amoxicillin
Trimox
Unicillin
Utimox
Vetramox
VETREMOX
Wymox
Zimox
ZOXYCIL 250
ZOXYCIL 500
Α-amino-p-hydroxybenzylpenicillin
|
|
44 |
|
Anidulafungin |
Approved, Investigational |
Phase 4 |
|
166663-25-8 |
166548 |
Synonyms:
(4R,5R)-4,5-DIHYDROXY-N²-[[4''-(PENTYLOXY)-P-TERPHENYL-4-YL]CARBONYL]-L-ORNITHYL-L-THREONYL-TRANS-4-HYDROXY-L-PROLYL-(S)-4-HYDROXY-4(P-HYDROXYPHENYL)-L-THREONYL-L-THREONYL-(3S,4S)-3-HYDROXY-4-METHYL-L-PROLINE CYCLIC (6->1)-PEPTIDE
1-((4R,5R)-4,5-Dihydroxy-N2-((4''-(pentyloxy)(1,1':4',1''-terphenyl)-4-yl)carbonyl)-L-ornithine)-echinocandin b
ANIDULAFUNGIN
Anidulafungina
Anidulafungine
Anidulafunginum
D70013
|
ECALTA
Eraxis
LY303366
LY-303366
V-ECHINOCANDIN
VER002
VER-002
|
|
45 |
|
Chenodeoxycholic acid |
Approved |
Phase 4 |
|
474-25-9 |
10133 |
Synonyms:
(+)-CHENODEOXYCHOLATE
(+)-CHENODEOXYCHOLIC ACID
(3A,5B,7A)-3,7-DIHYDROXY-CHOLAN-24-OATE
(3A,5B,7A)-3,7-DIHYDROXY-CHOLAN-24-OIC ACID
(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R)-5,9-DIHYDROXY-2,15-DIMETHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADECAN-14-YL]PENTANOIC ACID
(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-10,13-DIMETHYL-3,7-BIS(OXIDANYL)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL]PENTANOIC ACID
(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-DIHYDROXY-10,13-DIMETHYL-2,3,4,5,6,7,8,9,11,12,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL]PENTANOIC ACID
(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-DIHYDROXY-10,13-DIMETHYL-2,3,4,5,6,7,8,9,11,12,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL]VALERIC ACID
3A,7A-DIHYDROXY-5B,14A,17B-CHOLANATE
3A,7A-DIHYDROXY-5B,14A,17B-CHOLANIC ACID
3A,7A-DIHYDROXY-5B-CHOLAN-24-OATE
3A,7A-DIHYDROXY-5B-CHOLAN-24-OIC ACID
3A,7A-DIHYDROXY-5B-CHOLANATE
3A,7A-DIHYDROXY-5B-CHOLANIC ACID
3alpha,7alpha-Dihydroxy-5beta-cholanate
3ALPHA,7ALPHA-DIHYDROXY-5BETA-CHOLANIC ACID
3Α,7α-dihydroxy-5β-cholanate
3Α,7α-dihydroxy-5β-cholanic acid
7A-HYDROXY-DESOXYCHOLSAEURE
7a-Hydroxylithocholate
7a-Hydroxylithocholic acid
7alpha-Hydroxylithocholate
7ALPHA-HYDROXYLITHOCHOLIC ACID
7Α-hydroxylithocholate
7Α-hydroxylithocholic acid
Acid, chenic
Acid, chenique
Acid, chenodeoxycholic
Acid, gallodesoxycholic
Acide chenodeoxycholique
Acido chenodeoxicholico
Acidum chenodeoxycholicum
Anthropodeoxycholate
ANTHROPODEOXYCHOLIC ACID
Anthropodesoxycholate
|
ANTHROPODESOXYCHOLIC ACID
Antigen brand OF chenodeoxycholic acid
CDCA
CDCA|Chenix®|chenodeoxycholate|Chenodiol®|Leadiant® (formerly Chenodeoxycholic acid sigma-tau)
Chenate
CHENDOL 125
CHENDOL 250
CHENIC ACID
Chenique acid
CHENIX
CHENOCEDON
CHENOCHOLIC ACID
CHENODEOXYCHOLATE
Chenodeoxycholate, sodium
CHENODEOXYCHOLIC ACID
CHENODESOXYCHOLIC ACID
CHENODESOXYCHOLSAEURE
CHENODIOL
CHENOFALK
Chenophalk
COMBIDOL
Estedi brand OF chenodeoxycholic acid
Falk brand OF chenodeoxycholic acid
Gallodesoxycholate
GALLODESOXYCHOLIC ACID
Henohol
LITHOFALK
NSC-657949
Quenobilan
Quenocol
Sodium chenodeoxycholate
Solvay brand OF chenodeoxycholic acid
Tramedico brand OF chenodeoxycholic acid
XENBILOX
Zambon brand OF chenodeoxycholic acid
|
|
46 |
|
Bismuth subsalicylate |
Approved, Vet_approved |
Phase 4 |
|
14882-18-9 |
53629521 16682734 |
Synonyms:
2-Hydroxy-benzo[1,3,2]dioxabismin-4-one
Basic bismuth salicylate
Basic bismuth salicylic acid
BISMUKOTE
Bismuth
Bismuth oxide salicylate
Bismuth oxide salicylic acid
Bismuth oxysalicylate
Bismuth oxysalicylic acid
BISMUTH SUBSALICYLATE
Bismuth subsalicylic acid
Bismuth(III) subsalicylate
|
Bismuthi subsalicylas
Bismutum subsalicylicum
CORRECTIVE SUSPENSION
GASTRO-COTE
Helidac
Kaopectate
Pepto-bismol
Pink bismuth
Subsalicylate bismuth
Trigastronol
Wismutsubsalicylat
|
|
47 |
|
Clarithromycin |
Approved |
Phase 4 |
|
81103-11-9 |
84029 |
Synonyms:
6-O-METHYL ERYTHROMYCIN
6-O-Methylerythromycin
6-O-Methylerythromycin a
A-56268
ABBOTT-56268
Biaxin
BIAXIN XL
BIAXIN XL PAC
CAM
CLA
CLARIE XL
CLARITHROMYCIN
CLARITHROMYCIN EXTENDED RELEASE
CLARITHROMYCIN IDENTITY
Clarithromycina
Clarithromycine
|
Clarithromycinum
Claritromicina
CLAROSIP
Clathromycin
FEBZIN XL
KLARICID
KLARICID 500
KLARICID ADULT
KLARICID I.V.
KLARICID PAED
KLARICID XL
MYCIFOR XL
PREVPAC
TE-031
XETININ XL
ZECLAR
|
|
48 |
|
Ropivacaine |
Approved |
Phase 4 |
|
84057-95-4 |
71273 175805 |
Synonyms:
(-)-1-Propyl-2',6'-dimethyl-2-piperidylcarboxyanilide
(-)-1-Propyl-2',6'-pipecoloxylidide
(+-)-Ropivacaine
(S)-(-)-1-Propyl-2',6'-pipecoloxylidide
(S)-(−)-1-PROPYL-2',6'-PIPECOLOXYLIDIDE
(S)-ROPIVACAINE
1 Propyl 2',6' pipecoloxylidide
1-Propyl-2',6'-dimethyl-2-piperidylcarboxyanilide
1-Propyl-2',6'-pipecoloxylidide
1-propyl-2',6'-pipecoloxylidide|AL-381|LEA-103|Naropin®|ropivacaine hydrochloride
AL-381
DL-Ropivacaine
LEA 103
LEA-103
L-N-N-Propylpipecolate-2,6-xylidide
L-N-N-Propylpipecolic acid-2,6-xylidide
Naropeine
|
Naropin
N-N-Propylpipecolate-2,6-xylidide
N-N-Propylpipecolic acid-2,6-xylidide
Racemic ropivacaine
rac-Ropivacaine
Ropivacaina
Ropivacaina [INN-Spanish]
Ropivacaina [Spanish]
Ropivacaine
Ropivacaine [INN]
Ropivacaine hydrochloride
Ropivacaine monohydrochloride
Ropivacaine monohydrochloride, (S)-isomer
Ropivacainum
Ropivacainum [INN-Latin]
S-Ropivacaine
|
|
49 |
|
Nadroparin |
Approved, Investigational |
Phase 4 |
|
|
|
Synonyms:
|
50 |
|
Neostigmine |
Approved, Vet_approved |
Phase 4 |
|
59-99-4 |
4456 5824 |
Synonyms:
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamic acid
[3-(DIMETHYLCARBAMOYLOXY)PHENYL]-TRIMETHYL-AMMONIUM
[3-(DIMETHYLCARBAMOYLOXY)PHENYL]-TRIMETHYLAZANIUM
[3-(DIMETHYLCARBAMOYLOXY)PHENYL]-TRIMETHYL-AZANIUM
[3-[DIMETHYLAMINO(OXO)METHOXY]PHENYL]-TRIMETHYLAMMONIUM
3-Trimethylammoniumphenyl N,N-dimethylcarbamate
3-Trimethylammoniumphenyl N,N-dimethylcarbamic acid
BLOXIVERZ
Bromide, neostigmine
Eustigmin
Eustigmine
Methylsulfate, neostigmine
m-Trimethylammoniumphenyldimethylcarbamate
m-Trimethylammoniumphenyldimethylcarbamic acid
Neostigmina
NEOSTIGMINE
|
Neostigmine bromide
NEOSTIGMINE METHYL SULFATE
Neostigmine methylsulfate
NEOSTIGMINE METILSULFATE
NSC-93753
Polstigmine
Proserine
Prostigmin
PROSTIGMIN (TN)
Prostigmin®
Prostigmine
Prozerin
ROBINUL-NEOSTIG
Synstigmin
Syntostigmine
Vagostigmine
|
|
Interventional clinical trials:
(show top 50)
(show all 8969)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Evaluation of the Effects of Laying Early (Between 12 and 16) a Gastric Band on the Prevention of Morbid Obesity in Late Adolescence. Randomized Checked Against Standard Management of Obesity in This Population. |
Unknown status |
NCT01700738 |
Phase 4 |
|
2 |
Prevention and Control of Obesity in Primary School Children in Tehran |
Unknown status |
NCT02082080 |
Phase 4 |
|
3 |
A Study of the Pharmacokinetics of Dexmedetomidine in Morbid Obesity. |
Unknown status |
NCT01864187 |
Phase 4 |
Dexmedetomidine |
4 |
The Effect of Moxonidine and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension: a Randomised, Double Blind, Active Comparator Clinical Trial |
Unknown status |
NCT01360710 |
Phase 4 |
Moxonidine;Irbesartan |
5 |
Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Overweight and Obesity Patients With Newly Diagnosed Type 2 Diabetes Mellitus: A Randomized Control Study |
Unknown status |
NCT02999841 |
Phase 4 |
Acarbose;Vildagliptin |
6 |
Effect of Saxagliptin on Body Fat , Glucose and Beta Cell Function in Patients With Newly Diagnosed Pre-Diabetes Mellitus and Obesity |
Unknown status |
NCT01960205 |
Phase 4 |
Saxagliptin;saxagliptin;metformin |
7 |
The Therapeutic Effect of Catgut Embedding in Obesity-A Randomized, Double-blind, Placebo-controlled Clinical Trial |
Unknown status |
NCT02276235 |
Phase 4 |
|
8 |
Trial Evaluating Effectiveness of Contrave (Naltrexone HCl / Bupropion HCl) for Weight Maintenance in Adults With BMI ≥ 27 Kg/m2, After 6 Month Intensive Behavior Modification Program: Contrave Obesity Trials (COR) Weight Maintenance Study |
Unknown status |
NCT04589130 |
Phase 4 |
Contrave 8Mg-90Mg Extended-Release Tablet;Placebo |
9 |
Comparing Dexlansoprazole With Double-dose Lansoprazole to Achieve Sustained Symptomatic Response in Overweight and Obesity Patients With Reflux Esophagitis in Los Angeles Grades A & B |
Unknown status |
NCT02759393 |
Phase 4 |
Dexlansoprazole;Lansoprazole |
10 |
The Effect of Obesity in Dexmedetomidine Metabolic Clearance |
Unknown status |
NCT02557867 |
Phase 4 |
Dexmedetomidine |
11 |
Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome: a Double-blind Placebo-controlled Clinical Trial |
Unknown status |
NCT04453306 |
Phase 4 |
Topiramate;Placebo |
12 |
Effect and Safety of Benaglutide or Metformin in Patients With Simple Obesity Who Have Inadequate Weight Control :A Randomized, Open, Controlled and Single-site Clinical Trail |
Unknown status |
NCT03593668 |
Phase 4 |
Metformin;Benaglutide |
13 |
Double-blind Randomized Trial Using Oral Metformin Versus Placebo in the Treatment of Acanthosis Nigricans in Children With Obesity |
Unknown status |
NCT02438020 |
Phase 4 |
Metformin |
14 |
Assessment of the Effect of Moxonidine and Diet on Cardiac, Renal and Endothelial Function in Young Subjects With Abdominal Obesity |
Unknown status |
NCT01180231 |
Phase 4 |
Moxonidine (Physiotens) |
15 |
Correlation of Postoperative VAS Values and Body Mass Index in Patients Undergoing Abdominal Surgery: A Clinical Trial |
Unknown status |
NCT02017314 |
Phase 4 |
Morphine |
16 |
Prospective Randomized Study of Effects of Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Sleeve Gastrectomy |
Unknown status |
NCT00667706 |
Phase 4 |
|
17 |
Laparoscopic Non Banded Vertical (Magenstrasse and Mill) Gastroplasty In Bariatric Surgery. Morbidity and Results on Weight Loss and Associated Co-morbidities |
Unknown status |
NCT02050477 |
Phase 4 |
|
18 |
Comparing the Efficacy of Two Frequently Used Doses of Enoxaparin for VTE Prophylaxis After Bariatric Surgery |
Unknown status |
NCT01970202 |
Phase 4 |
40mg Enoxaparin;60mg Enoxaparin |
19 |
Effect of Docosahexaenoic Acid Supplementation on Microbiome in Obese ChiLdrEn. The DAMOCLE Study |
Unknown status |
NCT04151758 |
Phase 4 |
Docosahexaenoic Acid Supplementation |
20 |
Laparoscopic Bariatric Surgery: Impact of the Level of Neuromuscular Blockade on Surgical Conditions - Comparison Between Moderate and Deep Neuromuscular Blockade |
Unknown status |
NCT02118844 |
Phase 4 |
rocuronium |
21 |
Preoperative Carbohydrate Loading in Bariatric Surgery - Randomized Clinical Trail |
Unknown status |
NCT04486079 |
Phase 4 |
|
22 |
Effect of POSTbiotics Supplementation on Microbiome in OBese Children: the POST-OB Study |
Unknown status |
NCT04151823 |
Phase 4 |
Vitamin D3;Immunofos |
23 |
Prospective, Pharmacokinetic Study for Determination of the Relationship Between Lean Body Weight and Anti-Xa Activity 4 Hours After Subcutaneous Injection of 5700 IU Nadroparin in Morbidly Obese Patients After Bariatric Surgery. |
Unknown status |
NCT02295150 |
Phase 4 |
Nadroparin |
24 |
Gut Hormones as Mediators of Different Weight Loss Responses After Roux-en-Y Gastric Bypass |
Unknown status |
NCT02374632 |
Phase 4 |
|
25 |
Could Gut Microbiome Contribute to the Therapeutic Effect of Liraglutide 3.0 mg? A Randomized Double Blind Placebo Controlled Trial |
Unknown status |
NCT04046822 |
Phase 4 |
Liraglutide 6 MG/ML [Saxenda];Placebo |
26 |
Healthy Opportunities for Physical Activity and Nutrition (HOP'N) After-School Project |
Unknown status |
NCT01015599 |
Phase 4 |
|
27 |
Laparoscopic Roux-en-Y Gastric Bypass vs. Laparoscopic BPD-Duodenal Switch for Superobesity (BMI > 50 kg/m2)- A Randomized Clinical Trial |
Unknown status |
NCT00327912 |
Phase 4 |
|
28 |
International, Multi Centre, Open, Prospective, Randomized Study: Banded Versus Conventional Laparoscopic Roux-en-Y (GABY) |
Unknown status |
NCT01015469 |
Phase 4 |
|
29 |
The Effect of Vitamin A Supplementation on CD4+ T-cell Secretion in Obese Individuals |
Unknown status |
NCT01405352 |
Phase 4 |
|
30 |
Levonorgestrel-releasing Intrauterine Device Effects on Hemostatic and Arterial Function of Obese Women |
Unknown status |
NCT01320917 |
Phase 4 |
|
31 |
Endobarrier Treatment in Obese Subjects With T2DM |
Unknown status |
NCT01718457 |
Phase 4 |
|
32 |
Structured Exerise Training in Infertile Obese Patients Treated With Assisted Reproductive Techniques: a Randomized Controlled Trial |
Unknown status |
NCT01892111 |
Phase 4 |
|
33 |
Efficacy and Safety of Liraglutide-bolus (Liraglutide Plus Prandial Insulin) Versus Glargine-bolus Therapy in Overweight / Obese Patients With Uncontrolled Type 2 Diabetes (LiraGooD)--A Multicenter Randomized Controlled Study |
Unknown status |
NCT03087032 |
Phase 4 |
Liraglutide;insulin glargine |
34 |
Effects of Valsartan on Metabolic Syndrome in Patients With Hypertension |
Unknown status |
NCT00790946 |
Phase 4 |
Valsartan |
35 |
Evaluation of Family Intervention Program for the Treatment of Overweight or Obese Children (Nereu Program): Randomized Clinical Trial |
Unknown status |
NCT01878994 |
Phase 4 |
|
36 |
Influence of Erythromycin on ad Libitum Food Intake and the Evaluation of Motilin in Food Timing in Healthy Volunteers and Patients |
Unknown status |
NCT03024879 |
Phase 4 |
Erythromycin;Saline |
37 |
Study of Metabolic Effects of EndoBarrier Versus Intragastric Balloon in Obese Patients With Type 2 Diabetes. |
Unknown status |
NCT01848795 |
Phase 4 |
|
38 |
Beijing Chao-yang Hospital, Capital Medical University |
Unknown status |
NCT02583438 |
Phase 4 |
Saxagliptin (Bristol-Myers Squibb Company) |
39 |
A 24-Week, National, Single-Centre, Open-Labelled, Randomised, Parallel-Group Trial Comparing Energy Expenditure With Insulin Detemir Versus NPH Insulin Using a Basal-Bolus Regimen With Insulin Aspart as the Mealtime Insulin in Subjects With Type 2 Diabetes |
Unknown status |
NCT00788840 |
Phase 4 |
Insulatard;Detemir |
40 |
Randomisation to Endoluminal Intestinal Liner Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity) |
Unknown status |
NCT02055014 |
Phase 4 |
Liraglutide |
41 |
Synergy Effect of the Appetite Hormone GLP-1 (LiragluTide) and Exercise on Maintenance of Weight Loss and Health After a Low Calorie Diet - the S-LiTE Randomized Trial |
Unknown status |
NCT04122716 |
Phase 4 |
Liraglutide |
42 |
The Efficacy of a Once Weekly Glucagon-Like Peptide-1 Agonist on Body Weight/Composition and Metabolic Parameters in Persons With SCI |
Unknown status |
NCT03292315 |
Phase 4 |
Exenatide 2 MG Injection [Bydureon] |
43 |
The Effect of Mirabegron on Brown Adipose Tissue in Healthy Young White Caucasian and South Asian Men |
Unknown status |
NCT03012113 |
Phase 4 |
Mirabegron;Placebo Oral Capsule |
44 |
The Effect of Exenatide on Brown Adipose Tissue Activity and Energy Expenditure in Healthy Young Men |
Unknown status |
NCT03002675 |
Phase 4 |
Bydureon |
45 |
Sildenafil Activates Browning of White Adipose and Improves Insulin Sensitivity in Human Adults |
Unknown status |
NCT02524184 |
Phase 4 |
sildenafil;placebo |
46 |
The Effect of Hydroxychloroquine Sulphate on Hedonic Food Intake, Appetite-related Sensations and Gastrointestinal Hormone Release in Overweight Female Subjects |
Unknown status |
NCT04005781 |
Phase 4 |
Hydroxychloroquine sulphate;Placebo |
47 |
The Effect of Hydroxychloroquine Sulphate on Hedonic Food Intake, Appetite-related Sensations and Gastrointestinal Hormone Release in Healthy Female Subjects |
Unknown status |
NCT04005768 |
Phase 4 |
Hydroxychloroquine Sulphate;Placebo |
48 |
Metformin Treatment for Preventing Gestational Diabetes in High-risk Patients |
Unknown status |
NCT00883259 |
Phase 4 |
Metformin |
49 |
The Effects of Cortisol Blockade on Nutritional Sympathetic Nervous System Responsiveness in Overweight and Obese Subjects With Metabolic Syndrome |
Unknown status |
NCT01620684 |
Phase 4 |
metyrapone;placebo |
50 |
A Pilot Study: Comparing Physiological Parameters and Outcome Variables Using Pressure Support Ventilation Versus Pressure Controlled Ventilation in Patients With Chronic Respiratory Failure |
Unknown status |
NCT00994552 |
Phase 4 |
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Benzphetamine
Benzphetamine hydrochloride
Dexfenfluramine
Dexfenfluramine Hydrochloride
Diethylpropion
Diethylpropion Hydrochloride
Fenfluramine
Fenfluramine Hydrochloride
lorcaserin
lorcaserin hydrochloride
Mazindol
Methamphetamine
orlistat
|
phendimetrazine
PHENDIMETRAZINE HYDROCHLORIDE
phendimetrazine tartrate
Phenmetrazine
Phenmetrazine Hydrochloride
Phentermine
Phentermine Hydrochloride
PHENTERMINE RESIN
Phenylpropanolamine
Phenylpropanolamine Hydrochloride
sibutramine
SIBUTRAMINE HYDROCHLORIDE
|
Cochrane evidence based reviews: obesity
|